BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Pharm Country

  4 Sell-Ranked Drug Stocks To Avoid Ahead Of Q2 Earnings

  July 17, 2017

   · 

  1 min read
• BioCapital

  5 Top Growth Stocks In Biotech Right Now

  July 17, 2017

   · 

  1 min read
• Pharm Country

  Pfizer Is Set To Lose Its No. 1 Spot Among Drugmakers: Here’s Why It Doesn’t Matter

  July 17, 2017

   · 

  1 min read
• 

  Business

  The Quest of the Ambitious New Generation of Family-Run Boehringer Ingelheim

  July 17, 2017

   · 

  2 min read
• 

  Deals

  Debt-Ridden Valeant Dumps Another Asset in $190 Million Cash Deal

  July 17, 2017

   · 

  3 min read
• Drug Development

  No Relief For Investors As The FDA Keeps Partial Hold On Repros Therapeutics’s Proellex Program

  July 17, 2017

   · 

  4 min read
• Drug Development

  Can-Fite BioPharma’s Phase II NAFLD/NASH Trial With Namodenoson Set To Commence Patient Enrollment Following Conclusion Of Successful Clinical Investigator Meeting

  July 17, 2017

   · 

  7 min read
• Drug Development

  WAVE Life Sciences Initiates Two Phase 1b/2a Clinical Trials: PRECISION-HD1 And PRECISION-HD2 In Patients With Huntington’s Disease

  July 17, 2017

   · 

  7 min read
• Drug Development

  Apexigen Announces First Patient Dosed In Phase Ib/II Clinical Trial Of APX005M In Combination With Opdivo (Nivolumab) In Advanced Solid Tumors

  July 17, 2017

   · 

  3 min read
• Policy

  TherapeuticsMD Provides TX-004HR Regulatory Update

  July 17, 2017

   · 

  5 min read